Mark Chin - Jul 16, 2021 Form 4 Insider Report for IMARA Inc. (ELVN)

Role: Director
Signature: /s/ Michael P. Gray, Attorney-in-Fact
Stock symbol: ELVN
Transactions as of: Jul 16, 2021
Transactions value $: $7,999,998
Form type: 4
Date filed: 7/28/2021, 08:50 AM
Previous filing: Jun 30, 2021
Next filing: Oct 7, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELVN	Common Stock	Purchase	$8M	+1.33M	+131.92%	$6.00	2.34M	Jul 16, 2021	By entities affiliated with Arix Bioscience plc	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are directly beneficially owned by Arix Bioscience Holdings Limited ("Arix Ltd."). Arix Bioscience Plc ("Arix Plc") is the sole owner and parent of Arix Ltd. and may be deemed to indirectly beneficially own the shares held by Arix Ltd. Mr. Chin is a managing director of Arix plc. Each of Arix plc and Mr. Chin disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein.

Content

The shares are directly beneficially owned by Arix Bioscience Holdings Limited ("Arix Ltd."). Arix Bioscience Plc ("Arix Plc") is the sole owner and parent of Arix Ltd. and may be deemed to indirectly beneficially own the shares held by Arix Ltd. Mr. Chin is a managing director of Arix plc. Each of Arix plc and Mr. Chin disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein.